The hospital anxiety and depression scale, in patients with multiple sclerosis

Código QR

The hospital anxiety and depression scale, in patients with multiple sclerosis

José Luís Pais-Ribeiro,1,2 Ana Martins da Silva,3,4 Estela Vilhena,5 Inês Moreira,3 Ernestina Santos,3,4 Denisa Mendonça6 1William James Center for Research, ISPA – University Institute, Lisboa, Portugal; 2Faculty of Psychology and Education Scie...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pais-Ribeiro JL, Martins da Silva A, Vilhena E, Moreira I, Santos E, Mendonça D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Multiple sclerosis Depression Anxiety HADS Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/53e094f08f6b4d11803f903b4296f4f2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Psychometric Properties of the HADS Measure of Anxiety and Depression Among Multiple Sclerosis Patients in Croatia
por: Ana Jerković, et al.
Publicado: (2021)

Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial
por: Penelope Smyth, et al.
Publicado: (2021)

Multiple sclerosis international
Publicado: (2010)

Real living with multiple sclerosis
Publicado: (1993)

Risk of Psychiatric Disorders in Multiple Sclerosis: A Nationwide Cohort Study in an Asian Population
por: Huang YC, et al.
Publicado: (2021)

A Study on The Hospital Anxiety and Depression Scale (HADS)
por: Didem Tetik Kucukelci
Publicado: (2019)

Assessment of the Hospital Anxiety and Depression Scale for cancer patients
por: Villoria,Erica, et al.
Publicado: (2018)

Multiple sclerosis clinical and laboratory research.

Emotional Distress in Cancer Patients During the First Wave of the COVID-19 Pandemic
por: Patricia Toquero, et al.
Publicado: (2021)

Impact of COVID-19 pandemic on anxiety, depression and distress – online survey results amid the pandemic in Russia
por: O. A. Karpenko, et al.
Publicado: (2020)

Effectiveness of Group Therapy Based on Acceptance and Commitment on the Severity of Fatigue and Depression With the Moderating role of Alexithymia in Patients With Multiple Sclerosis
por: Tahereh Haji Seyed Javadi, et al.
Publicado: (2020)

Paroxysmal symptoms among Iraqi patients with multiple sclerosis at Dr. Saad Al Witri-neurosciences hospital
por: Mustafa Makki Muqdad
Publicado: (2021)

OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS
por: E. P. Evdoshenko, et al.
Publicado: (2014)

T–CELL VACCINE PREPARATION FOR MULTIPLE SCLEROSIS TREATMENT
por: I. P. Ivanova, et al.
Publicado: (2014)

Adaptive Affect: The Nature of Anxiety and Depression
por: Morris DW
Publicado: (2019)

Depression and anxiety
Publicado: (1996)

Effect of Multiple Sclerosis and Its Treatments on Male Fertility: Cues for Future Research
por: Claudia Massarotti, et al.
Publicado: (2021)

Remitting long-standing major depression in a multiple sclerosis patient with several concurrent conditions
por: Sachinvala ND, et al.
Publicado: (2018)

Impact of Andropause on Multiple Sclerosis
por: Maria C. Ysrraelit, et al.
Publicado: (2021)

CYTOKINES AND HERPESVIRUSES IN CHILDREN WITH MULTIPLE SCLEROSIS
por: G. F. Zheleznikova, et al.
Publicado: (2016)

Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review
por: Elsbernd PM, et al.
Publicado: (2021)

The Toronto Hospital Alertness Test scale: relationship to daytime sleepiness, fatigue, and symptoms of depression and anxiety
por: Shahid A, et al.
Publicado: (2016)

PHENOTYPIC CHARACTERIZATION AND INTRACELLULAR CYTOKINES OF MEMORY T-CELLS IN MULTIPLE SCLEROSIS PATIENTS AFTER T-CELL VACCINATION
por: I. P. Ivanova, et al.
Publicado: (2012)

Use of the Hospital Anxiety and Depression Scale and the Taiwanese Depression Questionnaire for screening depression in head and neck cancer patients in Taiwan
por: Lee Y, et al.
Publicado: (2016)

Effects of Polyphenol Supplementations on Improving Depression, Anxiety, and Quality of Life in Patients With Depression
por: Kelly Lin, et al.
Publicado: (2021)

The features of reproductive health in women with multiple sclerosis
por: O. A. Tikhonovskaya, et al.
Publicado: (2017)

Nutrition in Multiple Sclerosis: An integrative review of scientific publications from the last 5 years
por: Silva,Bruna Yhang da Costa, et al.
Publicado: (2019)

Prevalence of Depression and Anxiety and Related Factors in Patients With Parkinson’s Disease
por: Mohammad Pir Hayati, et al.
Publicado: (2021)

Inside MS [official publication of the National Multiple Sclerosis Society] /

Anxiety and depression in patients with osteoarthritis: impact and management challenges
por: Sharma A, et al.
Publicado: (2016)

Psychometric Properties of The Goldberg Anxiety and Depression Scale (GADS) In Ecuadorian Population
por: Geovanny Genaro Reivan-Ortiz, et al.
Publicado: (2019)

A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine
por: Ariana R. Tagliaferri, et al.
Publicado: (2021)

ESTRIOL IN FUNCTIONAL MODULATION OF REGULATORY LYMPHOCYTES IN MULTIPLE SCLEROSIS
por: I. V. Nekrasova, et al.
Publicado: (2014)

Graves’ disease with spontaneous resolution following ocrelizumab in primary progressive multiple sclerosis
por: Duarte Diana Borges, et al.
Publicado: (2021)

Comparison of familial and sporadic multiple sclerosis in Iraqi patients
por: Hasan A. Al-hamadani, et al.
Publicado: (2021)

Migraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report
por: Mohammad Mahdi Rabiei, et al.
Publicado: (2021)

Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis
por: Elisabet Lopez-Soley, et al.
Publicado: (2021)

LDL and HDL lipoprotein subfractions in multiple sclerosis patients with decreased insulin sensitivity
por: Radikova Zofia, et al.
Publicado: (2018)

CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS
por: I. P. Ivanova, et al.
Publicado: (2021)

MICROBIAL AGENTS AS TRIGGERS OF MULTIPLE SCLEROSIS DEVELOPMENT
por: Yu. Froltsova, et al.
Publicado: (2019)